Cite
Effects of glucose‐lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: An updated meta‐analysis of randomized controlled trials with external adjudication of events.
MLA
Mannucci, Edoardo, et al. “Effects of Glucose‐lowering Agents on Cardiovascular and Renal Outcomes in Subjects with Type 2 Diabetes: An Updated Meta‐analysis of Randomized Controlled Trials with External Adjudication of Events.” Diabetes, Obesity & Metabolism, vol. 25, no. 2, Feb. 2023, pp. 444–53. EBSCOhost, https://doi.org/10.1111/dom.14888.
APA
Mannucci, E., Gallo, M., Giaccari, A., Candido, R., Pintaudi, B., Targher, G., & Monami, M. (2023). Effects of glucose‐lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: An updated meta‐analysis of randomized controlled trials with external adjudication of events. Diabetes, Obesity & Metabolism, 25(2), 444–453. https://doi.org/10.1111/dom.14888
Chicago
Mannucci, Edoardo, Marco Gallo, Andrea Giaccari, Riccardo Candido, Basilio Pintaudi, Giovanni Targher, and Matteo Monami. 2023. “Effects of Glucose‐lowering Agents on Cardiovascular and Renal Outcomes in Subjects with Type 2 Diabetes: An Updated Meta‐analysis of Randomized Controlled Trials with External Adjudication of Events.” Diabetes, Obesity & Metabolism 25 (2): 444–53. doi:10.1111/dom.14888.